Madhav MENON Yale School of MedicineUnited States

I am an Associate professor and director of research in Kidney transplantation at Yale University School of Medicine. My research has focused on mechanisms of proteinuria and renal fibrosis underlying GWAS-identified genetic variants and non-HLA mismatches that also associate with allograft CKD. Our group has experience with human biopsy tissue and blood RNA/ DNA assays, PBMC evaluations, and morphometry applied to cohort studies. Using genotype-phenotype information from two prospective cohort studies we evaluated outcomes of APOL1-risk genotype transplant recipients and identified a novel immunologic role for APOL1 risk variants (CKD-associated variant in African-ancestry). Currently we are investigating this T-cell phenotype using novel Bac-transgenic mouse models, and its relevance to FSGS. My current research funding includes NIDDK for my work on SHROOM3, the role of AMPK signaling as a “switch” modulating podocyte survival between Minimal change disease and FSGS, from the Dept of Defense to study APOL1-variant Tcells.

31 MARCH 2023

Time Session
15:45
16:45
John Cijiang He Chairperson United States
Sinee Disthabanchong Chairperson Faculty of Medicine, Ramathibodi Hospital, Mahidol UniversityThailand
  • Podocyte-specific NUP160 Knockout Mice Develop Nephrotic Syndrome and Glomerulosclerosis
    Professor Dr Zihua Yu Free Communication zihuayu@vip.sina.comFujian Children’s HospitalChina
  • Q and A
  • Comparison of Serum Sodium Following Intravenous Fluid Isotonic and Hypotonic Solution in Younger Children: A Randomized Controlled Trial
    Ornatcha SIRIMONGKOLCHAIYAKUL Free Communication Vajira hospital, Navamindradhiraj universityThailand
  • Q and A
  • Vitamin B Complex in Patients with Acute Kidney Injury The Vibaki Trial
    Rolando Claure-Del Granado Free Communication Hospital Obrero No 2 - C.N.S.Bolivia
  • Q and A
  • BAC-transgenic mice show a novel T-cell intrinsic role for FSGS-associated APOL1 risk-variants in T-cell activation
    Madhav MENON Free Communication Yale School of MedicineUnited States
  • Q and A
  • Distribution, Preparedness and Management of Ukrainian Adult Refugees on Dialysis
    Dmytro IVANOV Free Communication National Medical UniversityUkraine
  • Q and A
  • SGLT2 Inhibitor Treatment May Enhance Kidney Oxygenation and Attenuate HIF1A Expression in Young Persons with Type 2 Diabetes
    Viji Nair Free Communication University of Michigan Medical CenterUnited States
  • Q and A
MR 110